Protocolos Otros Países

output-onlinepngtools.png
info 1@3x.png
arrow&v
Guidance for surveillance of SARS-CoV-2 variants: Interim guidance, 9 August 2021
09/08/2021
Eng
SARS-CoV-2 variant data update, England
06/08/2021
Esp
Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)
04/08/2021
Eng
Holding gatherings during the COVID-19 pandemic: WHO policy brief
03/08/2021
Eng
Holding gatherings during the COVID-19 pandemic: WHO policy brief, 2 August 2021
03/08/2021
Eng
Annexes to the interim recommendations for use of theChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)
30/07/2021
Eng
Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)
30/07/2021
Eng
Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection
15/07/2021
Eng
WHO technical consultation on oxygen access scale-up for COVID-19
14/07/2021
Eng
Safe Eid al Adha practices in the context of COVID-19
13/07/2021
Eng
Infection prevention and control during health care when coronavirus disease (‎COVID-19)‎ is suspected or confirmed
12/07/2021
Eng
COVID-19 Vaccines: safety surveillance manual. Module on safety surveillance of COVID-19 vaccines in pregnant and breastfeeding women
12/07/2021
Eng
Risk assessment for SARS-CoV-2 variant: LAMBDA (VUI-21JUN-01, C.37)
08/07/2021
Eng
Therapeutics and COVID-19: living guideline
06/07/2021
Eng
Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19
02/07/2021
Eng
Technical considerations for implementing a risk-based approach to international travel in the context of COVID-19: Interim guidance
02/07/2021
Eng
Implementation guidance for assessments of frontline service readiness: strengthening real-time monitoring of health services in the context of the COVID-19 pandemic
01/07/2021
Eng
Protocol template to be used as template for observational study protocols for sentinel surveillance of adverse events of special interest (AESIs) after vaccination with COVID-19 vaccines.
01/07/2021
Eng
Ethical Framework for WHO’s work in the ACT-Accelerator
01/07/2021
Eng
Indicator framework for the evaluation of the public health effectiveness of digital proximity tracing solutions
25/06/2021
Eng
Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities
25/06/2021
Eng
Considerations for quarantine of contacts of COVID-19 cases
25/06/2021
Eng
SARS-CoV-2 variants of concern and variants under investigation in England
25/06/2021
Eng
Managing family risk: A facilitator’s toolbox for empowering families to manage risks during COVID-19 - Part 2
18/06/2021
Eng
A family toolbox for managing health and happiness during COVID-19 - Part 1
18/06/2021
Eng
Hypertension and COVID-19
17/06/2021
Eng
Management Protocol for Long Haul COVID-19 Syndrome (LHCS)
16/06/2021
Eng
Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19
15/06/2021
Eng
Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine
15/06/2021
Eng
Considerations for implementing and adjusting public health and social measures in the context of COVID-19
14/06/2021
Eng
Update on WHO Interim recommendations on COVID-19 vaccination of pregnant and lactating women
10/06/2021
Eng
Young people and COVID-19: Behavioural considerations for promoting safe behaviours
09/06/2021
Eng
How to manage COVID-19 vaccines without VVM at vaccination service points?
03/06/2021
Eng
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
01/06/2021
Eng
Use of medical and non-medical/fabric masks for community outreach activities during the COVID-19 pandemic
01/06/2021
Eng
Annexes to the recommendations for use of the Sinovac-CoronaVac vaccine against COVID-19: Grading of evidence, Evidence to recommendation tables
01/06/2021
Eng
Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines
01/06/2021
Eng
Preventing and mitigating COVID-19 at work
19/05/2021
Eng
WHO COVID-19 infection prevention and control (IPC) pillar achievements.
14/05/2021
Eng
Programmatic innovations to address challenges in tuberculosis prevention and care during the COVID-19 pandemic
13/05/2021
Eng
AstraZeneca ChAdOx1-S/nCoV-19 [recombinant], COVID-19 vaccine
10/05/2021
Eng
Estimating COVID-19 vaccine effectiveness against severe acute respiratory infections (‎SARI)‎ hospitalizations associated with laboratory-confirmed SARS-CoV-2: an evaluation using the test-negative design
06/05/2021
Eng
COVID-19 Exercise Programme - Drills for Vaccine Deployment
03/05/2021
Eng
Disability considerations for COVID-19 vaccination: WHO and UNICEF policy brief
26/04/2021
Eng
Expanding our understanding of post COVID-19 condition: report of a WHO webinar
24/04/2021
Eng
Annexes to the interim recommendations for use of theChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222, SII Covishield, SK Bioscience)
20/04/2021
Eng
Disability considerations for COVID-19 vaccination: WHO and UNICEF policy brief
19/04/2021
Eng
Asthma and COVID-19: scientific brief
19/04/2021
Eng
Why are there extra doses of vaccine in the vaccine vial?
16/04/2021
Eng
WHO COVID-19 essential supplies forecasting tool (‎COVID-ESFT)
14/04/2021
Eng
Reducing public health risks associated with the sale of live wild animals of mammalian species in traditional food markets
12/04/2021
Eng
WHO COVID-19 infection prevention and control (IPC) pillar achievements. February 2020 – January 2021
06/04/2021
Eng
Principles for COVID-19 Vaccination in Musculoskeletal and Rheumatology for Clinicians
31/03/2021
Eng
WHO-convened global study of origins of SARS-CoV-2: China Part
30/03/2021
Eng
Background document on the Janssen Ad26.COV2.S (COVID-19) vaccine: Background document to the WHO Interim recommendations for use of Ad26.COV2.S (COVID-19) vaccine
17/03/2021
Eng
How to monitor and report COVID-19 vaccine side effects
15/03/2021
Eng
Monitoring COVID-19 vaccination: Considerations for the collection and use of vaccination data
03/03/2021
Eng
Monitoring COVID-19 vaccination: Considerations for the collection and use of vaccination data
03/03/2021
Eng
WHO Living guideline: Drugs to prevent COVID-19
02/03/2021
Eng
WHO Living guideline: Drugs to prevent COVID-19
02/03/2021
Eng
COVID-19 vaccine checklist
01/03/2021
Eng
Health worker communication for COVID-19 vaccination flow diagram
01/03/2021
Eng
COVID-19 vaccine checklist
01/03/2021
Eng
Operational considerations to expedite genomic sequencing component of GISRS surveillance of SARS-CoV-2
17/02/2021
Eng
Using face masks in the community: first update - Effectiveness in reducing transmission of COVID-19
15/02/2021
Eng
Interim recommendations for use of the AZD1222 (ChAdOx1-S (recombinant)) vaccine against COVID-19 developed by Oxford University and AstraZeneca
10/02/2021
Eng
Global COVID-19 Clinical Platform Case Report Form (CRF) for Post COVID condition (Post COVID-19 CRF)
09/02/2021
Eng
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
08/02/2021
Eng
Definition and categorization of the timing of mother-to-child transmission of SARS-CoV-2
07/02/2021
Eng
Data for action: achieving high uptake of COVID-19 vaccines: Interim Guidance
03/02/2021
Eng
Background document on the mRNA-1273 vaccine (Moderna) against COVID-19
03/02/2021
Eng
Contact tracing in the context of COVID-19
01/02/2021
Eng
Protocolos de atención odontológica ante la nueva realidad por COVID-19
31/01/2021
Esp
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
28/01/2021
Eng
Recomendaciones FACME para la vacunación frente a COVID-19
28/01/2021
Esp
Las nuevas cepas del SARS-CoV-2, ¿qué se sabe?
26/01/2021
Esp
COVID-19 Clinical management: living guidance
25/01/2021
Eng
Actualización - Estrategia de vacunación frente a COVID-19 en España
25/01/2021
Esp
Online global consultation on contact tracing for COVID-19, 9-11 June 2020
22/01/2021
Eng
Strategies for Optimizing the Supply of Isolation Gowns
21/01/2021
Eng
mRNA-1273 vaccine (Moderna) against COVID-19 Background document (draft)
19/01/2021
Eng
Sequencing of SARS-CoV-2 - Version 1
18/01/2021
Eng
WHO public health research agenda for managing infodemics
18/01/2021
Eng
Investigational COVID-19 Convalescent Plasma
15/01/2021
Eng
Protecting Participants in Bioequivalence Studies for Abbreviated New Drug Applications During the COVID-19 Public Health Emergency
15/01/2021
Eng
Aide-memoire: Infection prevention and control (IPC) principles and procedures for COVID-19 vaccination activities
15/01/2021
Eng
Coronavirus Disease 2019 (COVID-19) Treatment Guidelines
14/01/2021
Eng
Analysing and using routine data to monitor the effects of COVID-19 on essential health services: practical guide for national and subnational decision-makers
14/01/2021
Eng
Analysing and using routine data to monitor the effects of COVID-19 on essential health services: practical guide for national and subnational decision-makers
14/01/2021
Eng
Coagulation Systems for Measurement of Viscoelastic Properties: Enforcement Policy During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency
14/01/2021
Eng
COVID-19: Potency Assay Considerations for Monoclonal Antibodies and Other Therapeutic Proteins Targeting SARS-CoV-2 Infectivity
13/01/2021
Eng
Product Information as approved by the CHMP on 8 January 2021, pending endorsement by the European Commission
08/01/2021
Eng
Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing
08/01/2021
Eng
Genomic sequencing of SARS-CoV-2: a guide to implementation for maximum impact on public health
08/01/2021
Eng
SARS-CoV-2 genomic sequencing for public health goals: Interim guidance
08/01/2021
Eng
Infection prevention and control guidance for long-term care facilities in the context of COVID-19 update
08/01/2021
Eng
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 - Version 3.6.0
08/01/2021
Eng
COVID-19 Rapid Response Team Guidance
08/01/2021
Eng
How to Make 0.1% Chlorine Solution to Disinfect Surfaces in Healthcare Settings
08/01/2021
Eng
¿Cómo atender a pacientes con COVID-19?
07/01/2021
Esp
Providing Care and Treatment for People Living with HIV in Low-Resource Non-US Settings During COVID-19 Pandemic
07/01/2021
Eng
CHMP summary of positive opinion for COVID-19 Vaccine Moderna
06/01/2021
Eng
COVID-19 Vaccine Moderna - Product information
06/01/2021
Eng
Summary of the Risk Management Plan for COVID-19 Vaccine Moderna
06/01/2021
Eng
Guidance on Providing Pediatric Well-Care During COVID-19
06/01/2021
Eng
COVID-19 Guidance for Safe Schools
05/01/2021
Eng
Interim Guidance on Supporting the Emotional and Behavioral Health Needs of Children, Adolescents, and Families During the COVID-19 Pandemic
05/01/2021
Eng
Risk of False Results with the Curative SARS-Cov-2 Test for COVID-19: FDA Safety Communication
04/01/2021
Eng
Capacitación para personal de salud sobre vacunación contra la COVID-19: Módulos
01/01/2021
Esp
Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19
30/12/2020
Esp
COVID-19 Testing Guidance
30/12/2020
Eng
Cloth Face Coverings
30/12/2020
Eng
Guidance on the Use of Personal Protective Equipment (PPE) for Pediatric Care in Ambulatory Care Settings During the SARS-CoV-2 Pandemic
30/12/2020
Eng
Information for Pediatric Healthcare Providers
30/12/2020
Eng
COVID-19 Global Risk Communication and Community Engagement Strategy
23/12/2020
Eng
Evidence to recommendations: Methods used for assessing health equity and human rights considerations in COVID-19 and aviation
23/12/2020
Eng
COVID-19 in children and the role of school settings in transmission - Version 1
23/12/2020
Eng
Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages
23/12/2020
Eng
Comirnaty : EPAR - All authorised presentations
22/12/2020
Eng
Comirnaty : EPAR - Public assessment report
22/12/2020
Eng
Commission adopts Recommendation on EU coordinated approach to travel and transport in response to new variant of coronavirus in the UK
22/12/2020
Eng
COVID-19 vaccination and prioritisation strategies in the EU/EEA
22/12/2020
Eng
Comirnaty: EPAR - Product Information
21/12/2020
Eng
Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19
21/12/2020
Eng
CHMP summary of positive apinion for Comirnaty
20/12/2020
Eng
COVID-19 rapid guideline: managing the long-term effects of COVID-19
18/12/2020
Eng
Emergency Use Designation of COVID-19 candidate vaccines: Ethical considerations for current and future COVID-19placebo-controlled vaccine trials and trial unblinding
18/12/2020
Eng
Proposal for a council recommendation on a common framework for the use, validation and mutual recognition of COVID-19 rapid antigen tests in the EU
18/12/2020
Eng
Coronavirus (covid-19): medidas de prevención y control de la infección
18/12/2020
Esp
Since advice in a crisis
18/12/2020
Esp
COVID-19 rapid guideline: vitamin D
17/12/2020
Eng
Therapeutics and COVID-19: living guideline - 3rd Version
17/12/2020
Eng
Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities
17/12/2020
Eng
Emergency Global Supply Chain System (COVID-19) catalogue
17/12/2020
Eng
Vaccines and Related Biological Products Advisory Committee Meeting
17/12/2020
Eng
Considerations for implementing a risk-based approach to international travel in the context of COVID-19
16/12/2020
Eng
Risk assessment tool to inform mitigation measures for international travel in the context of COVID-19
16/12/2020
Eng
COVID-19 diagnostic testing in the context of international travel
16/12/2020
Eng
Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities
16/12/2020
Eng
Evidence to recommendations: COVID-19 mitigation in the aviation sector: Interim guidance - Corrigenda
15/12/2020
Eng
Testing Healthcare Personnel
14/12/2020
Eng
Potential Exposure at Work
14/12/2020
Eng
Mitigating Staff Shortages
14/12/2020
Eng
Infection Control Guidance
14/12/2020
Eng
Coronavirus (COVID-19): evidencia relevante para cuidados críticos
12/12/2020
Esp
COVID-19 vaccine introduction and deployment costing tool
10/12/2020
Eng
Coronavirus disease 2019 (COVID-19) and supply ofsubstances of human origin in the EU/EEA - 2nd update
10/12/2020
Eng
Information for Healthcare Professionals on Pfizer/BioNTech COVID-19 vaccine
10/12/2020
Eng
Checklist to support schools re-opening and preparation for COVID-19 resurgences or similar public health crises
10/12/2020
Eng
Winter Holidays
09/12/2020
Eng
Supporting Healthy Nutrition and Physical Activity During the COVID-19 Pandemic
09/12/2020
Eng
Obesity Management and Treatment During COVID-19
09/12/2020
Eng
Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19)
08/12/2020
Eng
Interim Guidance for Antigen Testing for SARS-CoV-2
05/12/2020
Eng
COVID-19 Interim Guidance: Return to Sports
04/12/2020
Eng
Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths
04/12/2020
Eng
Guidance for Dental Settings
04/12/2020
Eng
Corrigenda – Maintaining surveillance of influenza and monitoring SARS-CoV-2
03/12/2020
Eng
Discontinuation of Isolation for Persons with COVID-19 Not in Healthcare Settings
03/12/2020
Eng
Care for Breastfeeding Women
03/12/2020
Eng
Guidelines for COVID-19 testing and quarantine of air travellers - Addendum to the Aviation Health Safety Protocol
02/12/2020
Eng
Feasibility, Potential Value and Limitations of Establishing a Closely Monitored Challenge Model of Experimental COVID-19 Infection and Illness in Healthy Young Adult Volunteers
02/12/2020
Eng
Public Health Guidance for Potential COVID-19 Exposure Associated with International or Domestic Travel
02/12/2020
Eng
Breastfeeding Guidance Post Hospital Discharge for Mothers or Infants with Suspected or Confirmed SARS-Co V-2 Infection
02/12/2020
Eng
Mask use in the context of COVID-19
01/12/2020
Eng
CDC Guidance for Expanded Screening Testing to Reduce Silent Spread of SARS-CoV-2
01/12/2020
Eng
Guidance for Health Departments about COVID-19 Testing in the Community
01/12/2020
Eng
Know When to Delay your Travel to Avoid Spreading COVID-19
01/12/2020
Eng
Staying safe from COVID-19 during winter
01/12/2020
Eng
Recommandations pour les repas de Noël
01/12/2020
Fr
Public Health Guidance for Potential COVID-19 Exposure Associated with International or Domestic Travel
30/11/2020
Eng
Local restriction tiers: what you need to know
30/11/2020
Eng
Evidence to recommendations: COVID-19 mitigation in the aviation sector
27/11/2020
Eng
Rapid hospital readiness checklist: Interim Guidance
26/11/2020
Eng
Draft landscape of COVID-19 candidate vaccines – 26 November 2020
26/11/2020
Eng
Know When to Delay your Travel to Avoid Spreading COVID-19
25/11/2020
Eng
Strategies for Optimizing the Supply of Facemasks
23/11/2020
Eng
Investigating a COVID-19 Case
23/11/2020
Eng
Contact Tracing for COVID-19
23/11/2020
Eng
Strategies for Optimizing the Supply of N95 Respirators
23/11/2020
Eng
Prioritizing Case Investigations and Contact Tracing for COVID-19 in High Burden Jurisdictions
23/11/2020
Eng
Polling Locations and Voters
23/11/2020
Eng
Prioritizing COVID-19 Contact Tracing Mathematical Modeling Methods and Findings
23/11/2020
Eng
Prioritizing COVID-19 Contact Tracing Mathematical Modeling Methods and Findings
23/11/2020
Eng
Collection and Submission of Postmortem Specimens from Deceased Persons with Known or Suspected COVID-19
22/11/2020
Eng
COVID-19 rapid guideline: reducing the risk of venous thromboembolism in over 16s with COVID-19
20/11/2020
Eng
Therapeutics and COVID-19: living guideline - 2nd Version
20/11/2020
Eng
Continuity of essential health services: Facility assessment tool
20/11/2020
Eng
Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19
20/11/2020
Eng
Priority medical devices list for the COVID-19 response and associated technical specifications
20/11/2020
Eng
Preparing for COVID-19 in Nursing Homes
20/11/2020
Eng
Maintaining surveillance of influenza and monitoring SARS-CoV-2 – adapting Global Influenza surveillance and Response System (GISRS) and sentinel systems during the COVID-19 pandemic
19/11/2020
Eng
Operational Considerations for Personal Protective Equipment in the Context of Global Supply Shortages for Coronavirus Disease 2019 (COVID-19) Pandemic: non-US Healthcare Settings
19/11/2020
Eng
Cleaning, Disinfection, and Hand Hygiene in Schools – a Toolkit for School Administrators
19/11/2020
Eng
Options for the use of rapid antigen tests for COVID-19 in the EU/EEA and the UK
19/11/2020
Eng
Contact tracing: public health management of persons, including healthcare workers, who have had contact with COVID-19 cases in the European Union – third update
18/11/2020
Eng
The COVID-19 Treatment Guidelines Panel’s Statement on the Emergency Use Authorization of Bamlanivimab for the Treatment of COVID-19
18/11/2020
Eng
Interim Operational Considerations for Public Health Management of Healthcare Workers Exposed to or with Suspected or Confirmed COVID-19: non-U.S. Healthcare Settings
18/11/2020
Eng
Considerations for Restaurant and Bar Operators
18/11/2020
Eng
Multisystem Inflammatory Syndrome in Children (MIS-C) Interim Guidance
17/11/2020
Eng

Fuentes

Ministère des Solidarités et de la Santé

SIAARTI

NICE

CMIM

CDC

Diabetes UK